Logo image of AMTX

AEMETIS INC (AMTX) Stock Fundamental Analysis

NASDAQ:AMTX - Nasdaq - US00770K2024 - Common Stock - Currency: USD

1.92  -0.06 (-2.78%)

After market: 1.99 +0.07 (+3.65%)

Fundamental Rating

2

Taking everything into account, AMTX scores 2 out of 10 in our fundamental rating. AMTX was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. AMTX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AMTX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AMTX has reported negative net income.
AMTX had a positive operating cash flow in the past year.
In the past 5 years AMTX always reported negative net income.
In multiple years AMTX reported negative operating cash flow during the last 5 years.
AMTX Yearly Net Income VS EBIT VS OCF VS FCFAMTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -39.12%, AMTX is doing worse than 97.06% of the companies in the same industry.
Industry RankSector Rank
ROA -39.12%
ROE N/A
ROIC N/A
ROA(3y)-33.47%
ROA(5y)-33.1%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMTX Yearly ROA, ROE, ROICAMTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

1.3 Margins

AMTX has a worse Gross Margin (0.80%) than 83.33% of its industry peers.
AMTX's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AMTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-45.42%
GM growth 5Y-19.26%
AMTX Yearly Profit, Operating, Gross MarginsAMTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

More info and screens

0

2. Health

2.1 Basic Checks

AMTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMTX has been increased compared to 1 year ago.
Compared to 5 years ago, AMTX has more shares outstanding
Compared to 1 year ago, AMTX has an improved debt to assets ratio.
AMTX Yearly Shares OutstandingAMTX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
AMTX Yearly Total Debt VS Total AssetsAMTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -2.75, we must say that AMTX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AMTX (-2.75) is worse than 77.94% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.75
ROIC/WACCN/A
WACC4.72%
AMTX Yearly LT Debt VS Equity VS FCFAMTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M 300M

2.3 Liquidity

A Current Ratio of 0.26 indicates that AMTX may have some problems paying its short term obligations.
With a Current ratio value of 0.26, AMTX is not doing good in the industry: 95.10% of the companies in the same industry are doing better.
A Quick Ratio of 0.11 indicates that AMTX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.11, AMTX is doing worse than 96.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.11
AMTX Yearly Current Assets VS Current LiabilitesAMTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

AMTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.52%.
Looking at the last year, AMTX shows a very strong growth in Revenue. The Revenue has grown by 59.51%.
Measured over the past years, AMTX shows a small growth in Revenue. The Revenue has been growing by 1.71% on average per year.
EPS 1Y (TTM)-72.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-152.05%
Revenue 1Y (TTM)59.51%
Revenue growth 3Y4.08%
Revenue growth 5Y1.71%
Sales Q2Q%18.56%

3.2 Future

The Earnings Per Share is expected to grow by 36.17% on average over the next years. This is a very strong growth
AMTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 41.65% yearly.
EPS Next Y-44.5%
EPS Next 2Y17.04%
EPS Next 3Y24.01%
EPS Next 5Y36.17%
Revenue Next Year55.8%
Revenue Next 2Y46.94%
Revenue Next 3Y52.22%
Revenue Next 5Y41.65%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMTX Yearly Revenue VS EstimatesAMTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B
AMTX Yearly EPS VS EstimatesAMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMTX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMTX Price Earnings VS Forward Price EarningsAMTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMTX Per share dataAMTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as AMTX's earnings are expected to grow with 24.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.04%
EPS Next 3Y24.01%

More info and screens

0

5. Dividend

5.1 Amount

AMTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AEMETIS INC

NASDAQ:AMTX (2/21/2025, 8:01:09 PM)

After market: 1.99 +0.07 (+3.65%)

1.92

-0.06 (-2.78%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-06 2025-03-06/amc
Inst Owners24.06%
Inst Owner Change-97.07%
Ins Owners8.5%
Ins Owner Change6.9%
Market Cap95.48M
Analysts76.67
Price Target11.78 (513.54%)
Short Float %14.46%
Short Ratio8.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.81%
Min EPS beat(2)-49.09%
Max EPS beat(2)11.47%
EPS beat(4)1
Avg EPS beat(4)-36.82%
Min EPS beat(4)-84.78%
Max EPS beat(4)11.47%
EPS beat(8)2
Avg EPS beat(8)-10.57%
EPS beat(12)4
Avg EPS beat(12)0.64%
EPS beat(16)5
Avg EPS beat(16)-3.9%
Revenue beat(2)1
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-11.46%
Max Revenue beat(2)5.4%
Revenue beat(4)1
Avg Revenue beat(4)-5.22%
Min Revenue beat(4)-11.46%
Max Revenue beat(4)5.4%
Revenue beat(8)1
Avg Revenue beat(8)-20.3%
Revenue beat(12)4
Avg Revenue beat(12)-12.18%
Revenue beat(16)4
Avg Revenue beat(16)-12.64%
PT rev (1m)-18.59%
PT rev (3m)-20%
EPS NQ rev (1m)4.88%
EPS NQ rev (3m)4.88%
EPS NY rev (1m)8.11%
EPS NY rev (3m)8.96%
Revenue NQ rev (1m)-12.69%
Revenue NQ rev (3m)-12.69%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF 7.01
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.26
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.27
OCFY14.26%
SpS5.86
BVpS-5.21
TBVpS-5.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.12%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.8%
FCFM N/A
ROA(3y)-33.47%
ROA(5y)-33.1%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-45.42%
GM growth 5Y-19.26%
F-Score4
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 353.75%
Cap/Sales 9.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.11
Altman-Z -2.75
F-Score4
WACC4.72%
ROIC/WACCN/A
Cap/Depr(3y)552.62%
Cap/Depr(5y)448.18%
Cap/Sales(3y)15.19%
Cap/Sales(5y)12.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-152.05%
EPS Next Y-44.5%
EPS Next 2Y17.04%
EPS Next 3Y24.01%
EPS Next 5Y36.17%
Revenue 1Y (TTM)59.51%
Revenue growth 3Y4.08%
Revenue growth 5Y1.71%
Sales Q2Q%18.56%
Revenue Next Year55.8%
Revenue Next 2Y46.94%
Revenue Next 3Y52.22%
Revenue Next 5Y41.65%
EBIT growth 1Y3.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.47%
EBIT Next 3Y74.28%
EBIT Next 5Y67.89%
FCF growth 1Y73.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.22%
OCF growth 3Y77.31%
OCF growth 5YN/A